ACTIVITY OVERVIEW | This Webcast contains video and downloadable slides from the symposium, Targeting the Right Chemotherapy to the Right Patient: Optimizing Outcomes in Breast Cancer, a prIME Oncology educational activity that was held on 23 September 2011 during the 2011 European Multidisciplinary Cancer Congress in Stockholm, Sweden. |
FACULTY | Co-Chairs
Luca Gianni, MD
San Raffaele Institute
Milan, Italy
Carsten Rose, MD
Lund University Hospital
Lund, Sweden
Faculty
Robert E. Coleman, MD, FRCP, FRCPE
University of Sheffield
Sheffield, United Kingdom
Christian Jackisch, MD, PhD
Klinikum Offenbach
Offenbach, Germany
Hope Rugo, MD
University of California
San Francisco
San Francisco, California,
United States |
TARGET AUDIENCE | This educational activity is specifically designed for pan-European medical oncologists, surgical and radiation oncologists, and other healthcare providers interested and/or involved in the treatment of patients with breast cancer. This meeting is restricted to healthcare professionals based outside of the United States.
|
|
|
 |
|
Expert Discussion
|
 |
|
Clinical Case
|
 |
|
Downloadable Slides
|
|
 |
TOPICS | Choosing the right chemotherapy: Where are we today?
Carsten Rose, MD
Redefining the role of taxanes in breast cancer: How should clinicians incorporate new data?
Hope Rugo, MD
Clinical scenario #1—Progressive metastatic breast cancer: A dilemma in search of practical solutions?
Christian Jackisch, MD, PhD
Clinical scenario #2—Managing disease recurrence after adjuvant chemotherapy: How can we fine tune our approach?
Robert E. Coleman, MD, FRCP, FRCPE
Clinical scenario #3—Optimizing therapeutic choices: How can clinicians use molecular phenotype to achieve this goal?
Hope Rugo, MD
|
LEARNING OBJECTIVES | After successful completion of this educational activity, participants should be able to:
- Discuss strategies to individualize chemotherapy for patients with breast cancer, including utilization of molecular profiling, biomarkers, and patient and disease characteristics
- Evaluate current standards of care for the use of chemotherapy in patients with breast cancer, and evaluate recent data regarding optimization of available therapies
- Examine the latest clinical trial data on novel chemotherapeutic agents and newer drug formulations and how these agents can be incorporated into current treatment regimens
- Identify appropriate treatment strategies for patients with heavily pretreated and/or refractory metastatic breast cancer
|
|
|
|
Organizer | This Webcast is a prIME Oncology activity.
|
SUPPORT | Support for this educational activity is provided by Celgene.
|
|
